Annet R. Rajan

FDA investigator

Appears on 16 documents from 2020 to 2026, mostly at sites in New Jersey. Most often cites production record review (21 CFR 211.192).

16
Documents on file
5.5
Observations per 483
2020
First seen
2026
Most recent

What they cite most

From 85 observations

Activity by year

2020: 1, 2021: 2, 2022: 2, 2023: 3, 2024: 3, 2025: 3, 2026: 2

Where

New Jersey 10 · Maryland 2 · Florida 1 · Japan 1 · New Hampshire 1 · South Carolina 1

Is Annet R. Rajan coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

16 documents, newest first
FirmOpen
483 Imprimis NJOF, LLCAug 18, 2026 · Ledgewoo d, New Jersey
483 Sincerus Florida, LLC dba SKNVMay 29, 2026 · Pompano Beach, Florida
483 Molecular PharmaGroup LLCAug 11, 2025 · New Providence, New Jersey
483 DERMARITE INDUSTRIES, LLCApr 8, 2025 · NORTH BERGEN, New Jersey
483 Bausch & Lomb IncorporatedFeb 27, 2025 · Greenville, South Carolina
483 Health Pharma USA LLCJul 3, 2024 · Rahway, New Jersey
483 United Therapeutics CorporationMay 2, 2024 · Silver Spring, Maryland

About this profile

What does Annet R. Rajan inspect?

Annet R. Rajan appears on 16 documents on file covering 14 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.67 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Annet R. Rajan is dated Aug 18, 2026.